Top Markets
Coin of the day
Enveric Biosciences, Inc. Enveric Biosciences, Inc.

Enveric Biosciences, Inc.

ENVB
Rangering i aksjer #38625
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse... Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.
Aksjekurs
$1.52
Markedsverdi
$907.46K
Endring (1 dag)
0.66%
Endring (1 år)
-88.59%
Land
US
Handel Enveric Biosciences, Inc. (ENVB)

Kategori

Utbytteavkastning for Enveric Biosciences, Inc. (ENVB)
Enveric Biosciences, Inc. (aksjesymbol: ENVB) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Enveric Biosciences, Inc. (ENVB) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter